These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 33391341)
21. Construction of a Diagnostic Model for Distinguishing Benign or Malignant Bone Cancer by Mining miRNA Expression Data. Zhang Y; Hu J; Li T; Hao S; Wu X Biochem Genet; 2023 Feb; 61(1):299-315. PubMed ID: 35861903 [TBL] [Abstract][Full Text] [Related]
22. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients. Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580 [TBL] [Abstract][Full Text] [Related]
23. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases. Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475 [TBL] [Abstract][Full Text] [Related]
24. An evolutionary learning-based method for identifying a circulating miRNA signature for breast cancer diagnosis prediction. Sathipati SY; Tsai MJ; Aimalla N; Moat L; Shukla SK; Allaire P; Hebbring S; Beheshti A; Sharma R; Ho SY NAR Genom Bioinform; 2024 Mar; 6(1):lqae022. PubMed ID: 38406797 [TBL] [Abstract][Full Text] [Related]
25. Survival associated miRNA signature in patients with head and neck carcinomas. Yerukala Sathipati S; Ho SY Heliyon; 2023 Jun; 9(6):e17218. PubMed ID: 37360084 [TBL] [Abstract][Full Text] [Related]
26. Hsa-miR-342-3p and hsa-miR-360 may be the key molecules that promote periodontitis in type 2 diabetes mellitus. Yu S; Wang R; Wang W Heliyon; 2024 Jun; 10(11):e32198. PubMed ID: 38873685 [TBL] [Abstract][Full Text] [Related]
27. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer. He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer. Jakob M; Mattes LM; Küffer S; Unger K; Hess J; Bertlich M; Haubner F; Ihler F; Canis M; Weiss BG; Kitz J Head Neck; 2019 Oct; 41(10):3499-3515. PubMed ID: 31355988 [TBL] [Abstract][Full Text] [Related]
29. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles. Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760 [TBL] [Abstract][Full Text] [Related]
30. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis. Yang G; Zhang Y; Yang J Front Oncol; 2019; 9():1207. PubMed ID: 31799184 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma. Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608 [TBL] [Abstract][Full Text] [Related]
32. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis. Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985 [TBL] [Abstract][Full Text] [Related]
33. Overexpression Of hsa-miR-664a-3p Is Associated With Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease Via Targeting FHL1. Zhong S; Chen C; Liu N; Yang L; Hu Z; Duan P; Shuai D; Zhang Q; Wang Y Int J Chron Obstruct Pulmon Dis; 2019; 14():2319-2329. PubMed ID: 31632001 [TBL] [Abstract][Full Text] [Related]
34. A six-microRNA signature can better predict overall survival of patients with esophagus adenocarcinoma. Lan T; Lu Y; Xiao Z; Xu H; He J; Hu Z; Mao W PeerJ; 2019; 7():e7353. PubMed ID: 31380150 [TBL] [Abstract][Full Text] [Related]
35. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis. Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288 [TBL] [Abstract][Full Text] [Related]
36. A 2 miRNAs-based signature for the diagnosis of atherosclerosis. Han X; Wang H; Li Y; Liu L; Gao S BMC Cardiovasc Disord; 2021 Mar; 21(1):150. PubMed ID: 33761890 [TBL] [Abstract][Full Text] [Related]
37. Screening and identification of potential novel biomarker for diagnosis of complicated Plasmodium vivax malaria. Kaur H; Sehgal R; Kumar A; Sehgal A; Bansal D; Sultan AA J Transl Med; 2018 Oct; 16(1):272. PubMed ID: 30286756 [TBL] [Abstract][Full Text] [Related]
38. Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer. Tang J; Ma W; Zeng Q; Tan J; Cao K; Luo L Dis Markers; 2019; 2019():3815952. PubMed ID: 31976020 [TBL] [Abstract][Full Text] [Related]
39. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation. Qu K; Zhang X; Lin T; Liu T; Wang Z; Liu S; Zhou L; Wei J; Chang H; Li K; Wang Z; Liu C; Wu Z Sci Rep; 2017 May; 7(1):1692. PubMed ID: 28490741 [TBL] [Abstract][Full Text] [Related]
40. A plasma 3-marker microRNA biosignature distinguishes spinal tuberculosis from other spinal destructive diseases and pulmonary tuberculosis. Liang Q; Jin W; Huang Z; Yin H; Liu S; Liu L; Song X; Wang Z; Fei J Front Cell Infect Microbiol; 2023; 13():1125946. PubMed ID: 36926516 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]